| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4764451
Max Phase: Preclinical
Molecular Formula: C40H43ClN2O7
Molecular Weight: 699.24
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC(=O)CCCl)c(OC)cc3c1[C@H](C2)N(C)CC3
Standard InChI: InChI=1S/C40H43ClN2O7/c1-42-16-13-26-21-33(46-4)35-23-29(26)30(42)18-24-6-9-28(10-7-24)48-34-20-25(8-11-32(34)45-3)19-31-38-27(14-17-43(31)2)22-36(47-5)39(40(38)49-35)50-37(44)12-15-41/h6-11,20-23,30-31H,12-19H2,1-5H3/t30-,31-/m0/s1
Standard InChI Key: OKQZUCALRIRPSW-CONSDPRKSA-N
Associated Targets(Human)
HEL 6614 Activities
K562 73714 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MDA-MB-231 73002 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MCF7 126967 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 699.24 | Molecular Weight (Monoisotopic): 698.2759 | AlogP: 7.69 | #Rotatable Bonds: 6 |
| Polar Surface Area: 78.93 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
| #RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: | CX Basic pKa: 8.27 | CX LogP: 7.02 | CX LogD: 5.80 |
| Aromatic Rings: 4 | Heavy Atoms: 50 | QED Weighted: 0.11 | Np Likeness Score: 1.44 |
References
| 1. Yang J,Hu S,Wang C,Song J,Chen C,Fan Y,Ben-David Y,Pan W. (2020) Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway., 186 [PMID:31784186] [10.1016/j.ejmech.2019.111898] |
Source
Source(1):